TY - JOUR
T1 - Cerebellar neuronal dysfunction accompanies early motor symptoms in spinocerebellar ataxia type 3
AU - Mayoral-Palarz, Kristin
AU - Neves-Carvalho, Andreia
AU - Duarte-Silva, Sara
AU - Monteiro-Fernandes, Daniela
AU - Maciel, Patrıćia
AU - Khodakhah, Kamran
N1 - Funding Information:
This work was supported by the National Institute of Neurological Disorders and Stroke [R01NS050808 to K.K.; F31NS105406 to K.M.-P.]; National funds through the Fundaçaõ para a Ciência e a Tecnologia (FCT) – project UIDB/50026/2020 and
Funding Information:
UIDP/50026/2020 [SFRH/BPD/118779/2016 to A.N.-C.; CEECIND/00685/2020 to S.D.-S.; SFRH/BD/147947/2019 to D.M.-F.]; and the ICVS Scientific Microscopy Platform, a member of the national infrastructure Portuguese Platform of Bioimaging [PPBI-POCI-01-0145-FEDER-022122]. Open Access funding provided by National Institute of Neurological Disorders and Stroke [R01NS050808 to K.K.]. Deposited in PMC for immediate release.
Funding Information:
This work was supported by the National Institute of Neurological Disorders and Stroke [R01NS050808 to K.K.; F31NS105406 to K.M.-P.]; National funds through the Fundaçaõ para a Ciência e a Tecnologia (FCT) – project UIDB/50026/2020 and UIDP/50026/2020 [SFRH/BPD/118779/2016 to A.N.-C.; CEECIND/00685/2020 to S.D.-S.; SFRH/BD/147947/2019 to D.M.-F.]; and the ICVS Scientific Microscopy Platform, a member of the national infrastructure Portuguese Platform of Bioimaging [PPBI-POCI-01-0145-FEDER-022122]. Open Access funding provided by National Institute of Neurological Disorders and Stroke [R01NS050808 to K.K.]. Deposited in PMC for immediate release.
Publisher Copyright:
© 2022. Published by The Company of Biologists Ltd.
PY - 2022/8
Y1 - 2022/8
N2 - Spinocerebellar ataxia type 3 (SCA3) is an adult-onset, progressive ataxia. SCA3 presents with ataxia before any gross neuropathology. A feature of many cerebellar ataxias is aberrant cerebellar output that contributes to motor dysfunction. We examined whether abnormal cerebellar output was present in the CMVMJD135 SCA3 mouse model and, if so, whether it correlated with the disease onset and progression. In vivo recordings showed that the activity of deep cerebellar nuclei neurons, the main output of the cerebellum, was altered. The aberrant activity correlated with the onset of ataxia. However, although the severity of ataxia increased with age, the severity of the aberrant cerebellar output was not progressive. The abnormal cerebellar output, however, was accompanied by non-progressive abnormal activity of their upstream synaptic inputs, the Purkinje cells. In vitro recordings indicated that alterations in intrinsic Purkinje cell pacemaking and in their synaptic inputs contributed to abnormal Purkinje cell activity. These findings implicate abnormal cerebellar physiology as an early, consistent contributor to pathophysiology in SCA3, and suggest that the aberrant cerebellar output could be an appropriate therapeutic target in SCA3.
AB - Spinocerebellar ataxia type 3 (SCA3) is an adult-onset, progressive ataxia. SCA3 presents with ataxia before any gross neuropathology. A feature of many cerebellar ataxias is aberrant cerebellar output that contributes to motor dysfunction. We examined whether abnormal cerebellar output was present in the CMVMJD135 SCA3 mouse model and, if so, whether it correlated with the disease onset and progression. In vivo recordings showed that the activity of deep cerebellar nuclei neurons, the main output of the cerebellum, was altered. The aberrant activity correlated with the onset of ataxia. However, although the severity of ataxia increased with age, the severity of the aberrant cerebellar output was not progressive. The abnormal cerebellar output, however, was accompanied by non-progressive abnormal activity of their upstream synaptic inputs, the Purkinje cells. In vitro recordings indicated that alterations in intrinsic Purkinje cell pacemaking and in their synaptic inputs contributed to abnormal Purkinje cell activity. These findings implicate abnormal cerebellar physiology as an early, consistent contributor to pathophysiology in SCA3, and suggest that the aberrant cerebellar output could be an appropriate therapeutic target in SCA3.
KW - Ataxia
KW - Cerebellum
KW - Purkinje cells
KW - SCA3
UR - http://www.scopus.com/inward/record.url?scp=85135596608&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85135596608&partnerID=8YFLogxK
U2 - 10.1242/dmm.049514
DO - 10.1242/dmm.049514
M3 - Article
C2 - 35660856
AN - SCOPUS:85135596608
SN - 1754-8403
VL - 15
JO - DMM Disease Models and Mechanisms
JF - DMM Disease Models and Mechanisms
IS - 8
M1 - dmm049514
ER -